Your browser doesn't support javascript.
loading
Cost analysis of GenoType® MTBDRplus and GenoType® MTBDRsl at the State Laboratory of São Paulo, Brazil
Figueredo, Lida Jouca de Assis; César, Aina Liz Alves; Ferrazoli, Lucilaine; Chimara, Erica; Vater, Maria Claudia; Silva, Suely Conceição Alves da; Kritski, Afrânio Lineu; Miranda, Silvana Spíndola de.
Affiliation
  • Figueredo, Lida Jouca de Assis; Universidade Federal de Minas Gerais. Faculdade de Medicina. Laboratório de Pesquisa em Micobactérias. Belo Horizonte. BR
  • César, Aina Liz Alves; Centro Universitário UNA. Belo Horizonte. BR
  • Ferrazoli, Lucilaine; Instituto Adolfo Lutz. Laboratório de Saúde Pública do Estado de São Paulo. São Paulo. BR
  • Chimara, Erica; Instituto Adolfo Lutz. Laboratório de Saúde Pública do Estado de São Paulo. São Paulo. BR
  • Vater, Maria Claudia; Universidade Federal do Rio de Janeiro. Faculdade de Medicina. Programa Acadêmico de Tuberculose. Rio de Janeiro. BR
  • Silva, Suely Conceição Alves da; Universidade Federal do Rio de Janeiro. Faculdade de Medicina. Programa Acadêmico de Tuberculose. Rio de Janeiro. BR
  • Kritski, Afrânio Lineu; Universidade Federal do Rio de Janeiro. Faculdade de Medicina. Programa Acadêmico de Tuberculose. Rio de Janeiro. BR
  • Miranda, Silvana Spíndola de; Universidade Federal de Minas Gerais. Faculdade de Medicina. Laboratório de Pesquisa em Micobactérias. Belo Horizonte. BR
Rev. Soc. Bras. Med. Trop ; 56: e0238, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1449347
Responsible library: BR1.1
ABSTRACT
ABSTRACT

Background:

We aimed to evaluate the costs of GenoType® MTBDRplus and MTBDRsl incurred during the diagnosis of first- and second-line drug-resistant tuberculosis (TB) in São Paulo, Brazil.

Methods:

Mean and activity-based costs of GenoType® were calculated in a referral laboratory for TB in Brazil.

Results:

The mean cost value and activity-based cost of GenoType® MTBDRplus were USD 19.78 and USD 35.80 and those of MTBDRsl were USD 54.25 and USD 41.85, respectively.

Conclusions:

The cost of GenoType® MTBDRplus was reduced owing to the high number of examinations performed and work optimization.

Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / Neglected Diseases Health problem: Goal 4: Health financing / Tuberculosis Database: LILACS Type of study: Health economic evaluation Country/Region as subject: South America / Brazil Language: English Journal: Rev. Soc. Bras. Med. Trop Journal subject: Tropical Medicine Year: 2023 Document type: Article / Project document Affiliation country: Brazil Institution/Affiliation country: Centro Universitário UNA/BR / Instituto Adolfo Lutz/BR / Universidade Federal de Minas Gerais/BR / Universidade Federal do Rio de Janeiro/BR
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / Neglected Diseases Health problem: Goal 4: Health financing / Tuberculosis Database: LILACS Type of study: Health economic evaluation Country/Region as subject: South America / Brazil Language: English Journal: Rev. Soc. Bras. Med. Trop Journal subject: Tropical Medicine Year: 2023 Document type: Article / Project document Affiliation country: Brazil Institution/Affiliation country: Centro Universitário UNA/BR / Instituto Adolfo Lutz/BR / Universidade Federal de Minas Gerais/BR / Universidade Federal do Rio de Janeiro/BR